Dirk Arnold, MD, PhD, medical director, Asklepios Tumour Biology Centre, discusses a phase 3 clinical trial investigating amivantamab in metastatic colorectal cancer.

Quadruplet therapy is now the accepted standard for patients newly diagnosed with myeloma who are ineligible for transplant; ...

From 2006 and 2016, there were significant reductions in stroke risk among adult patients receiving hemodialysis, which differed by sex and racial group.

A groundbreaking shift is happening in the treatment of chronic kidney disease thanks to the work of psychologist Mrs. Erika ...

Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs), whether defined as lack of hemoglobin response to typical ESA doses or need for higher ESA doses to reach hemoglobi ...

The person who received the bladder is doing well, and the successful transplant could offer hope to thousands of people with bladder dysfunction.

Photo: Inderbir Gill (R) with Nima Nassiri. Photo: Nick Carranza/UCLA Health ...

In an eight-hour procedure at Ronald Reagan UCLA Medical Center, surgeons from UCLA Health and Keck Medicine of USC performed ...

The first-of-its-kind clinical trial has been cleared by the Food and Drug Administration, according to pig producer eGenesis, which announced the step Tuesday with its partner OrganOx.

The first-of-its-kind clinical trial has been cleared by the FDA, according to pig producer eGenesis, which announced the step Tuesday with its partner OrganOx. An estimated 35,000 people in the U ...

Clinical trials are important because they have clear ... have end-stage kidney disease and have been on dialysis for at least six months. They must also be free from other serious medical problems.

HealthDay News — The US Food and Drug Administration (FDA) has approved the first-ever clinical ... on dialysis for at least 6 months and have no other serious medical problems. The trial ...